Certain profiles warrant more careful monitoring: Patients with existing diabetic retinopathy, particularly those with a history of poor blood sugar control Patients who have been diagnosed with or are at risk for age-related macular degeneration Those with hypertension, high cholesterol, or obstructive sleep apnea Patients with a small cup-to-disc ratio, which can only be assessed during a dilated eye exam Those starting semaglutide specifically, given its stronger association with both NAION and diabetic retinopathy compared to tirzepatide Knowing your individual risk profile before starting therapy, not after a vision change occurs, is the most effective approach
Constipation affects a significant portion of users and can range from mild to severe
While these treatments can help, there can be side effects
Essa a promessa que desperta o interesse de cientistas da Universidade de Copenhague , onde uma pesquisadora farmacutica estuda o papel de certos alimentos na liberao de um hormnio ligado saciedade e ao emagrecimento: o GLP-1 (peptdeo semelhante ao glucagon tipo 1)
Mild redness and a small raised area at the injection site are among the most frequently reported reactions and typically indicate a normal inflammatory response to the injection